NewsBot
06-29-2009, 01:50 PM
HealthDay - MONDAY, June 29 (HealthDay News) -- The immunosuppressive drug golimumab shows promise in treating rheumatoid arthritis patients who don't respond to other drugs, according to a new study. Golimumab is from the family of drugs called tumor necrosis factor-a (TNF-a) inhibitors.
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20090629/hl_hsn/newdrugpromisingagainstrheumatoidarthritis)
(From Yahoo Diseases)
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20090629/hl_hsn/newdrugpromisingagainstrheumatoidarthritis)
(From Yahoo Diseases)